PSMD5 and plasma cell myeloma: Interestingly, this is contrary to a previous report by Tsvetkov et al., who demonstrated that reduced expression of several different 19S proteasome subunits, including PSMD1, PSMD5, PSMD6, or PSMD10, correlated with higher relapse rates and a worse OS in patients with multiple myeloma [41].